BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ohta K, Kajiya M, Zhu T, Nishi H, Mawardi H, Shin J, Elbadawi L, Kamata N, Komatsuzawa H, Kawai T. Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities. J Neuroimmunol 2011;233:37-45. [PMID: 21176972 DOI: 10.1016/j.jneuroim.2010.11.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Ransohoff RM. To Sleep, Perchance to Survive? Trends Immunol 2019;40:273-4. [PMID: 30885539 DOI: 10.1016/j.it.2019.02.006] [Reference Citation Analysis]
2 Augustyniak D, Nowak J, Lundy FT. Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential. Curr Protein Pept Sci. 2012;13:723-738. [PMID: 23305360 DOI: 10.2174/138920312804871139] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
3 Mohseni S, Emtenani S, Emtenani S, Asoodeh A. Antioxidant properties of a human neuropeptide and its protective effect on free radical-induced DNA damage: ANTIOXIDANT PROPERTIES OF CATESTATIN AS AN ENDOGENOUS NEUROPEPTIDE. J Pept Sci 2014;20:429-37. [DOI: 10.1002/psc.2634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280:22-35. [PMID: 23246832 DOI: 10.1016/j.cellimm.2012.11.009] [Cited by in Crossref: 327] [Cited by in F6Publishing: 310] [Article Influence: 32.7] [Reference Citation Analysis]
5 Aresti Sanz J, El Aidy S. Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response. Psychopharmacology (Berl) 2019;236:1597-609. [PMID: 30997526 DOI: 10.1007/s00213-019-05224-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
6 Min C, Ohta K, Kajiya M, Zhu T, Sharma K, Shin J, Mawardi H, Howait M, Hirschfeld J, Bahammam L, Ichimonji I, Ganta S, Amiji M, Kawai T. The antimicrobial activity of the appetite peptide hormone ghrelin. Peptides 2012;36:151-6. [PMID: 22634233 DOI: 10.1016/j.peptides.2012.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
7 Campos-Salinas J, Caro M, Cavazzuti A, Forte-Lago I, Beverley SM, O'Valle F, Gonzalez-Rey E. Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens. J Immunol 2013;191:6040-51. [PMID: 24249730 DOI: 10.4049/jimmunol.1301921] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
8 Campos-Salinas J, Cavazzuti A, O'Valle F, Forte-Lago I, Caro M, Beverley SM, Delgado M, Gonzalez-Rey E. Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens. J Biol Chem 2014;289:14583-99. [PMID: 24706753 DOI: 10.1074/jbc.M114.560573] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
9 Choi KY, Napper S, Mookherjee N. Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation. Immunology. 2014;143:68-80. [PMID: 24666281 DOI: 10.1111/imm.12291] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
10 Feuilloley MGJ. Antidromic neurogenic activity and cutaneous bacterial flora. Semin Immunopathol 2018;40:281-9. [DOI: 10.1007/s00281-018-0671-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Escobar‐salom M, Torrens G, Jordana‐lluch E, Oliver A, Juan C. Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram ‐negatives. Biological Reviews. [DOI: 10.1111/brv.12830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bazaka K, Jacob MV, Chrzanowski W, Ostrikov K. Anti-bacterial surfaces: natural agents, mechanisms of action, and plasma surface modification. RSC Adv 2015;5:48739-59. [DOI: 10.1039/c4ra17244b] [Cited by in Crossref: 129] [Cited by in F6Publishing: 2] [Article Influence: 18.4] [Reference Citation Analysis]
13 Xu C, Guo Y, Qiao X, Shang X, Niu W, Jin M. Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent. Molecules. 2017;22. [PMID: 29135962 DOI: 10.3390/molecules22111963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
14 Lugo JM, Tafalla C, Oliva A, Pons T, Oliva B, Aquilino C, Morales R, Estrada MP. Evidence for antimicrobial and anticancer activity of pituitary adenylate cyclase-activating polypeptide (PACAP) from North African catfish (Clarias gariepinus): Its potential use as novel therapeutic agent in fish and humans. Fish & Shellfish Immunology 2019;86:559-70. [DOI: 10.1016/j.fsi.2018.11.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]